Betterchem
Health     Industry Portals     News     For Consumers     21CFR     Search     Site Map

 
ORPHENADRINE

 
 
Content specific to this active ingredient…

Drug Information
Prescribing and patient information from leading authorities

Drug Master Files
Type 2 master files on file at the FDA

Drug Recalls
For prescription drugs containing this active ingredient

Exclusivity
Patent and market exclusivity data

Federal Register
FR search results for this API

FDA Approved Labelling
Information found in this drug's package inserts

Research Links
Chemical identification and research citations

Title 21 Code of Federal Regulations
FDA regulations for this API

   

 


 

FDA Approval Activities for this Drug…

Orphenadrine Citrate Injection, 30 mg/mL, Bedford ANDA 40-463 3/4/03 Orphenadrine Citrate Extended-Release Tablets, 100 mg, Impax, ANDA 40-368 6/23/00 10/30/00 Orphenadrine Citrate Extended-Release Tablets, 100 mg, Approved 1/29/1999 Kiel , ANDA# 40-249 1/29/99 2/5/99 8/1/03 Orphenadrine Citrate Extended-release Tablets, 100 mg, Invamed ANDA 40-284 6/19/98 6/19/98 Orphenadrine Citrate Extended-release Tablets, 100 mg. Eon Labs Manufacturing, ANDA 40-327 2/15/00 2/17/00 Orphenadrine Citrate, Aspirin, & Caffeine Tablets,25 mg/385 mg, & 50 mg/770 mg/60 mg. Jerome Stevens ANDA 74-988 4/30/99 5/4/99 Orphengesic(Orphenadrine Citrate 25 mg, Aspirin 385 mg & Caffeine 30 mg) & Orphengesic Forte(Orphenadrine Citrate 50 mg, Aspirin 770 mg & Caffeine 60 mg). Par ANDA 75-141 ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE Tablet; 385MG;30MG;25MG NORGESIC 3M 013416 ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE Tablet; 770MG;60MG;50MG NORGESIC FORTE 3M 074654 ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE Tablet; 385MG;30MG;25MG ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE Eon 074654 ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE Tablet; 770MG;60MG;50MG ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE Eon 074817 ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE Tablet; 385MG;30MG;25MG INVAGESIC Geneva TECH 074817 ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE Tablet; 770MG;60MG;50MG INVAGESIC FORTE Geneva TECH 075141 ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE Tablet; 385MG;30MG;25MG ORPHENGESIC Par 075141 ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE Tablet; 770MG;60MG;50MG ORPHENGESIC FORTE Par 074988 ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE Tablet; 385MG;30MG;25MG ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE STEVENS J 074988 ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE Tablet; 770MG;60MG;50MG ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE STEVENS J 013055 ORPHENADRINE CITRATE Injection 30MG/ML NORFLEX 3M 040463 ORPHENADRINE CITRATE Injection 30MG/ML ORPHENADRINE CITRATE Bedford 087062 ORPHENADRINE CITRATE Injection 30MG/ML ORPHENADRINE CITRATE STERIS 084779 ORPHENADRINE CITRATE Injection 30MG/ML ORPHENADRINE CITRATE STERIS 012157 ORPHENADRINE CITRATE Tablet, Extended Release; 100MG NORFLEX 3M 040327 ORPHENADRINE CITRATE Tablet, Extended Release; 100MG ORPHENADRINE CITRATE Eon 040284 ORPHENADRINE CITRATE Tablet, Extended Release; 100MG ORPHENADRINE CITRATE Geneva TECH 040368 ORPHENADRINE CITRATE Tablet, Extended Release; 100MG ORPHENADRINE CITRATE Impax 040249 ORPHENADRINE CITRATE Tablet, Extended Release; 100MG ORPHENADRINE CITRATE KIEL | Orphenadrine Citrate Injection, Akorn, Inc., Approval | Norflex (Orphenadrine Citrate) Extended-Release Tablets and Injection, Graceway Pharma, Labeling Revision | Norflex (Orphenadrine Citrate) Injection, Graceway Pharma, Labeling Revision

^ FDA's latest approval appears at the bottom of this list. ^


 

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z

Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News

© 2008 Betterchem.com